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ern Europe. A multidisciplinary and pan European experts’ working group has been
established to discuss the development of best practices to optimise future HTAs
for HPV vaccination. RESULTS: Our research shows that a systematic, transparent
and comprehensive approach was inconsistently used in previous HTAs leading to
different conclusions. However, all HTAs raised some uncertainties and remaining
open questions at time of assessment that need to be further addressed. The ex-
perts’ group reached consensus on the following points: 1) Epidemiological trends
and projections of HPV infection and diseases should be considered to better esti-
mate the expected impact of vaccination on HPV burden; 2) Changes in knowledge,
perceptions and attitudes towards HPV vaccination should be documented, as they
may affect the medical and economical efficiency of vaccination programmes. 3)
Dynamic transmission models (accounting for herd immunity) should be used,
considering decision-analytic aspects (incremental comparisons, time horizon,
discounting, model validation), to help assessors handling validity and uncertain-
ties on key parameters (HPV transmission, vaccine effectiveness, duration of pro-
tection); 4) HPV vaccination as any health technology should be subject to an on-
going HTA process that integrates new monitoring outcomes and research
findings. CONCLUSIONS: HTAs of HPV vaccination were used to inform policy-
making for girls’ vaccination, while uncertainties remained at first assessment
time. Evidence generated since latest HTA should continuously be integrated in
new HTAs, to better inform country policy decisions and adjust/extend policies in
place accordingly.
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OBJECTIVES: To prospectively ascertain outcomes typical of the French national
experience with the Swedish Adjustable Gastric BandTM (SAGBTM) in a consecu-
tive-series, patient sample. METHODS: A common protocol for prospective data
collection was provided to both urban and rural centres across regions of continen-
tal France. The protocol stipulated collection of data for body mass index (BMI,
kg/m2), excess weight (kg), comorbidities, quality of life (QoL), and adverse events.
RESULTS: Thirty-one surgeons in 28 teams implanted SAGBs.The cohort of 517
patients included 88.0% female; mean age of 37.5 years; mean disease duration,
15.3 years; mean preoperative BMI, 41.2. Measures of obesity were significantly
reduced at 3 years, with a within-patient mean BMI reduction of 9.0 (95% CI: 8.5, 9.5;
p0.0001), excess body weight reduction of 24.5 kg (23.1, 25.9; p0.0001), and cor-
responding 47.4% EWL (44.3, 51.0). Arthropathy, hypertension, dyslipidemia, and
gastro-oesophageal reflux disease were the 4 most frequently cited comorbidities.
Comorbidity prevalence fell significantly from a baseline of 74.3% (773 reported
comorbidities in 381/513) to 27.2% (161 comorbidities in 116/424); thus, at 3-year
follow-up, 72.8% reported no comorbidity. The majority of SAGB patients (68.3%)
experienced no adverse events. Confirmed adverse events associated with the
SAGB procedure totaled 290, occurring in 31.7% of patients. An overall adverse
event rate of 0.19 events per patient-year.There was 1 unrelated death.Obesity-
specific BAROSTM and non-disease specific Euro-QoLTMpresented improvement
in QoL over 3 years post-SAGB implantation. Global QoL improvement was signif-
icantly associated with magnitude of BMI reduction (p0.001) CONCLUSIONS:
SAGB was effective at 3 yrs; BMI was reduced by 9.0 kg/m2, from 41.0 to 32.2 kg/m2.
Average number of comorbidities per patient decreased over time. The 3-year im-
plant-survival rate was 87.0%. SAGB-induced weight loss was associated with sub-
stantially improved QoL.
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OBJECTIVES: Thyroidectomy is the treatment of choice in most thyroid cacner
patients; however the incidence of complications after thyroidectomy cannot be
bypassed. However, there are few studies about the complication after thyroidec-
tomy using nationwide health claim data. The aim of this study was to investigate
the incidence of complications after thyroidectomy in patients with thyroid cancer
and its risk factor in South Korea. METHODS: We used national health claim data-
base between 2006 and 2010 including all hospital records covering almost every
population by national health insurance system. We included patients aged 20-120
years old with thyroid cancer ( ICD-10 codes of C73*) who underwent throidecto-
my(P4551-4, P4561) in 2008. To select newly diagnosed patients in 2008, we ex-
cluded all patients who were previously reported to have any type of cancer in-
cluding thyroid cancer, hypoparathyroidism, or vocal cord paralysis between 2006
and 2007. We conducted a follow-up survey of the selected subjects on the national
health claim database at least for 2 years after diagnosis. RESULTS: Patients who
underwent thyroidectomy for thyroid cancer treatment 15,811 (mean age:
48.112.6 years). Complication after surgery occurred in 1,148 (7.3%) patients dur-
ing follow up of 2.4 years; 5.7% of hypoparathyroidism and 1.7% vocal cord paral-
ysis. Only 3.6% of complication (2.6% hypoparathyroidism and 0.6% vocal cord
paralysis) was reported within 1 month after surgery. The development of compli-
cation was significantly related with higher age, highly advanced general hospital,
urban region. CONCLUSIONS: This study results suggest that postoperative care
for patients with thyroidectomy is important to detect complications and to treat
them appropriately especially in elderly. Further more study is required to identify
risk factors of complication after thyroidectomy.
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OBJECTIVES: Individuals with pre-existing multi-vessel disease (MVD) and type-II
diabetes mellitus (DM) are at increased risk of complications following coronary
revascularisation. The global rise in prevalence of DM warrants frequent monitor-
ing of medium-term outcomes in real-world patients undergoing contemporary
coronary artery bypass surgery (CABG) or percutaneous coronary intervention.
METHODS: We conducted a meta-analysis comparing the effectiveness of CABG
versus drug-eluting stents (DES) in the MVD-DM population. Using a set of pre-
specified criteria, a search strategy was developed to retrieve published reports to
date (April 2012) in the English language. An electronic search for non-randomised
controlled studies was conducted in five medical databases (MEDLINE, EMBASE,
PUBMED, CINAHL and the Cochrane). A panel comprising three reviewers were
involved in systematically screening the selected abstracts, whilst two performed
the data extraction. Data were pooled using both fixed- and random-effects mod-
els. Effects sizes were measured through relative risks (RR) and 95% confidence
intervals (CI). RESULTS: Of 13 reports that met our pre-specified criteria, we in-
cluded 11 studies which enrolled 4,162 patients (2,033 CABG and 2,129 DES). The
average length follow-up was 2.5 years (range 12- and 60-months). Whilst no sig-
nificant mortality benefit was observed by either CABG or DES at mean follow-up
(RR  0.9; 95%-CI: 0.6 to 1.3), CABG was associated with lower risk of myocardial
infarction (RR 0.5; 95%-CI: 0.4 to 0.8), repeat revascularisation (RR0.3; 95%-CI: 0.2
to 0.4), and MACCE (RR 0.7; 95%-CI: 0.6 to 0.8). In contrast, CABG was associated
with higher risk of cerebrovascular events (CVE) (RR 1.8; 95%-CI: 1.04 to 3.2). Both
procedures showed no significant difference in the combined outcome of all-cause
mortality, myocardial infarction or CVE (RR  0.9; 95%-CI: 0.8 to 1.1).
CONCLUSIONS: In a real-world population we demonstrated a unique finding of
increased risk of myocardial infarction with DES compared to CABG at mean fol-
low-up of 2.5 years.
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OBJECTIVES: Angiograms, whereby a tube is inserted in the arm or groin area and
threaded up to the heart to check for blocked arteries that may cause a heart attack,
is a necessary but complicated and expensive procedure. This study analyzed the
potential overuse of angiograms among patients who underwent coronary artery
bypass graft (CABG) surgery in Turkey. METHODS: Using the Turkish National
Health Insurance Database, patients undergoing CABG surgery in 2010 were iden-
tified using the appropriate International Classification of Disease 10th Revision
Clinical Modification (ICD-10-CM) diagnosis codes. From this group, patients with
more than one angiogram 3 months before surgery were identified. Regional vari-
ations were identified using a color-coded map. The relationship between hospital
quality and angiogram intensity was assessed using chi-square tests. Hospital
quality was determined using the previously validated CompQual index, which
uses hospital operational mortality and volume as inputs. RESULTS: Out of 39,410
patients identified, 6.65% had more than one angiogram 3 months prior to CABG
surgery. There was a wide variation in angiogram use across cities. The proportion
of CABG surgery patients with more than one angiogram was the highest in
Tekirdag (14.46%), followed by Afyonkarahisar (12.23%) and Erzurum (10.66%).
There was a significant relationship between hospital quality and overuse of an-
giograms. The highest quality hospitals had a higher proportion of patients with a
single angiogram prior to CABG surgery (p0.001). CONCLUSIONS: Angiograms,
although significantly important to detect blocked arteries, should be applied ef-
fectively. Excessive use of angiograms not only decreases the quality of health care
but also increases health care costs.
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OBJECTIVES: Bariatric surgery is highly complex process indicated for treating
morbid obesity. In the SUS the surgery provided is the laparotomical way. Objec-
tives of the study were: Elaboration of a rapid review about the effectiveness and
economical analysis of the bariatric surgery methods for the decision of incorpo-
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